Literature DB >> 16505352

Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

Tiina J Kotti1, Denise M O Ramirez, Brad E Pfeiffer, Kimberly M Huber, David W Russell.   

Abstract

The mevalonate pathway produces cholesterol and nonsterol isoprenoids, such as geranylgeraniol. In the brain, a fraction of cholesterol is metabolized in neurons by the enzyme cholesterol 24-hydroxylase, and this depletion activates the mevalonate pathway. Brains from mice lacking 24-hydroxylase excrete cholesterol more slowly, and the tissue compensates by suppressing the mevalonate pathway. Here we report that this suppression causes a defect in learning. 24-Hydroxylase knockout mice exhibit severe deficiencies in spatial, associative, and motor learning, and in hippocampal long-term potentiation (LTP). Acute treatment of wild-type hippocampal slices with an inhibitor of the mevalonate pathway (a statin) also impairs LTP. The effects of statin treatment and genetic elimination of 24-hydroxylase on LTP are reversed by a 20-min treatment with geranylgeraniol but not by cholesterol. We conclude that cholesterol turnover in brain activates the mevalonate pathway and that a constant production of geranylgeraniol in a small subset of neurons is required for LTP and learning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505352      PMCID: PMC1450160          DOI: 10.1073/pnas.0600316103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  The discovery and development of HMG-CoA reductase inhibitors.

Authors:  A Endo
Journal:  J Lipid Res       Date:  1992-11       Impact factor: 5.922

Review 2.  Targeting Rab GTPases to distinct membrane compartments.

Authors:  Suzanne Pfeffer; Dikran Aivazian
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 3.  Neurosteroids: endogenous regulators of the GABA(A) receptor.

Authors:  Delia Belelli; Jeremy J Lambert
Journal:  Nat Rev Neurosci       Date:  2005-07       Impact factor: 34.870

4.  Bioenergetic characterization of gamma-aminobutyric acid transporter of synaptic vesicles.

Authors:  J W Hell; R Jahn
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

Review 5.  Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation.

Authors:  D C Crick; D A Andres; C J Waechter
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

6.  Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning.

Authors:  D Zamanillo; R Sprengel; O Hvalby; V Jensen; N Burnashev; A Rozov; K M Kaiser; H J Köster; T Borchardt; P Worley; J Lübke; M Frotscher; P H Kelly; B Sommer; P Andersen; P H Seeburg; B Sakmann
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

7.  cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.

Authors:  E G Lund; J M Guileyardo; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

8.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

Review 9.  Chain elongation in the isoprenoid biosynthetic pathway.

Authors:  B A Kellogg; C D Poulter
Journal:  Curr Opin Chem Biol       Date:  1997-12       Impact factor: 8.822

10.  Structure of synaptogyrin (p29) defines novel synaptic vesicle protein.

Authors:  K Stenius; R Janz; T C Südhof; R Jahn
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more
  96 in total

1.  A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma.

Authors:  Jeffrey G McDonald; Daniel D Smith; Ashlee R Stiles; David W Russell
Journal:  J Lipid Res       Date:  2012-04-19       Impact factor: 5.922

2.  Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model.

Authors:  C Fang; V J Bolivar; J Gu; W Yang; S O Zeitlin; X Ding
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

3.  Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.

Authors:  Natalia Mast; Marjan Shafaati; Wahiduz Zaman; Wenchao Zheng; Deborah Prusak; Thomas Wood; G A S Ansari; Anita Lövgren-Sandblom; Maria Olin; Ingemar Bjorkhem; Irina Pikuleva
Journal:  Biochim Biophys Acta       Date:  2010-03-16

4.  Sterol-dependent nuclear import of ORP1S promotes LXR regulated trans-activation of apoE.

Authors:  Sungsoo Lee; Ping-Yuan Wang; Yangsik Jeong; David J Mangelsdorf; Richard G W Anderson; Peter Michaely
Journal:  Exp Cell Res       Date:  2012-06-20       Impact factor: 3.905

5.  Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol.

Authors:  Satoshi Endo; Toshiyuki Matsunaga; Chisato Ohta; Midori Soda; Ayano Kanamori; Yukio Kitade; Satoshi Ohno; Kazuo Tajima; Ossama El-Kabbani; Akira Hara
Journal:  Chem Biol Interact       Date:  2010-12-25       Impact factor: 5.192

6.  Getting a handle on Huntington's disease: the case for cholesterol.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Gen Sobue
Journal:  Nat Med       Date:  2009-03       Impact factor: 53.440

7.  Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.

Authors:  Yoshihiro Shidoji; Yuki Tabata
Journal:  J Lipid Res       Date:  2019-01-08       Impact factor: 5.922

Review 8.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

Review 9.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

10.  Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function.

Authors:  Joanna M Karasinska; Franz Rinninger; Dieter Lütjohann; Piers Ruddle; Sonia Franciosi; Janine K Kruit; Roshni R Singaraja; Veronica Hirsch-Reinshagen; Jianjia Fan; Liam R Brunham; Nagat Bissada; Rajasekhar Ramakrishnan; Cheryl L Wellington; John S Parks; Michael R Hayden
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.